Form 8-K - Current report:
SEC Accession No. 0000950170-25-065638
Filing Date
2025-05-07
Accepted
2025-05-07 16:06:53
Documents
13
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K btmd-20250501.htm   iXBRL 8-K 49178
2 EX-99.1 btmd-ex99_1.htm EX-99.1 518346
3 GRAPHIC img137956444_0.jpg GRAPHIC 22031
  Complete submission text file 0000950170-25-065638.txt   738747

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20250501.xsd EX-101.SCH 24814
15 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20250501_htm.xml XML 4706
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 25921328
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)